Literature DB >> 12867804

Autoimmune hepatitis revealed by atorvastatin.

Nicoletta Pelli1, Maurizio Setti, Paola Ceppa, Carlo Toncini, Francesco Indiveri.   

Abstract

Cases of acute hepatitis induced by statins (3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors) have been reported. A 65-year-old woman was admitted to our hospital because of fatigue, jaundice and altered liver function tests while on treatment with atorvastatin. On the basis of clinical, serological and histological findings, a score leading to a diagnosis of autoimmune hepatitis was reached. We suggest that atorvastatin may have revealed an underlying autoimmune hepatitis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12867804     DOI: 10.1097/00042737-200308000-00014

Source DB:  PubMed          Journal:  Eur J Gastroenterol Hepatol        ISSN: 0954-691X            Impact factor:   2.566


  20 in total

1.  Autoimmune hepatitis and thyroiditis associated with rifampin and pyrazinamide prophylaxis: an unusual reaction.

Authors:  Omar Khokhar; Christopher Gange; Stephen Clement; James Lewis
Journal:  Dig Dis Sci       Date:  2005-01       Impact factor: 3.199

2.  Safety profile of rosuvastatin: results of a prescription-event monitoring study of 11,680 patients.

Authors:  Rachna Kasliwal; Lynda V Wilton; Victoria Cornelius; Beate Aurich-Barrera; Saad A W Shakir
Journal:  Drug Saf       Date:  2007       Impact factor: 5.606

Review 3.  Overcoming 'ageism' bias in the treatment of hypercholesterolaemia : a review of safety issues with statins in the elderly.

Authors:  Terry A Jacobson
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

4.  An analysis of drug-induced liver injury, which showed histological findings similar to autoimmune hepatitis.

Authors:  Akiko Hisamochi; Masayoshi Kage; Tatsuya Ide; Teruko Arinaga-Hino; Keisuke Amano; Reiichiro Kuwahara; Kei Ogata; Ichiro Miyajima; Ryukichi Kumashiro; Michio Sata; Takuji Torimura
Journal:  J Gastroenterol       Date:  2015-10-30       Impact factor: 7.527

Review 5.  Statins in the treatment of dyslipidemia in the presence of elevated liver aminotransferase levels: a therapeutic dilemma.

Authors:  Rossana M Calderon; Luigi X Cubeddu; Ronald B Goldberg; Eugene R Schiff
Journal:  Mayo Clin Proc       Date:  2010-04       Impact factor: 7.616

6.  Fluvastatin and hepatic reactions: a signal from spontaneous reporting in Italy.

Authors:  Anita Conforti; Lara Magro; Ugo Moretti; Stefania Scotto; Domenico Motola; Francesco Salvo; Barbara Ros; Roberto Leone
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

Review 7.  Use of Statins in Patients With and Without Liver Disease.

Authors:  Prashanth Francis; Lisa Forman
Journal:  Clin Liver Dis (Hoboken)       Date:  2020-02-25

8.  Drug-induced Liver Injury.

Authors:  Stefan David; James P Hamilton
Journal:  US Gastroenterol Hepatol Rev       Date:  2010-01-01

9.  Overlap syndrome of autoimmune hepatitis and primary biliary cirrhosis triggered by fluvastatin.

Authors:  Satoshi Nakayama; Naoya Murashima
Journal:  Indian J Gastroenterol       Date:  2011-04-19

Review 10.  Lipid-lowering agents that cause drug-induced hepatotoxicity.

Authors:  Sidharth S Bhardwaj; Naga Chalasani
Journal:  Clin Liver Dis       Date:  2007-08       Impact factor: 6.126

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.